Keyword: Turning Point Therapeutics

Publicly traded hotel companies beholden to Wall Street

Top 10 biotech IPOs in 2019

The big question at the start of 2019 was whether the IPO window would stay open for biotech companies, particularly those seeking to pull off ever-larger IPOs at increasingly earlier stages of development. The short answer is yes—kind of.